India launches indigenous vaccine for Japanese encephalitis

October 4, 2013

India on Friday launched an indigenous vaccine against Japanese encephalitis as part of a national programme to fight the virus.

Nineteen states, including the two most populous ones of Uttar Pradesh and Bihar, are hit by the disease each year as succumb to the virus which is transmitted by mosquitoes from pigs to humans.

"Beginning with the first report in 1955 in Tamil Nadu state, JE virus has now spread to over 171 districts in 19 states," Health Minister Ghulam Nabi Azad said at the launch of the vaccine called Jenvac in New Delhi.

The two-shot vaccine was developed by government agencies and the private Bharat Biotec pharmaceutical firm in a joint venture launched in 2008.

The minister said Jenvac, which offers immunity for three years, would initially cost the government 70 rupees ($1.13) but would be supplied free of charge to the people.

He said India so far had been dependent on China for the vaccine and added that the cost of the locally-developed Jenvac would slide with the scale of production.

"We will eventually need about 10 million doses of the for comprehensive coverage," the minister said.

The virus, which normally affects aged below 15, infected adults earlier this year in the northeastern state of Assam, Azad said.

He said the cabinet has approved a 40-billion rupee national programme to combat the , which causes brain inflammation and can result in brain damage.

Symptoms include headaches, seizures and fever and health experts say 70 million children nationwide are at risk.

Explore further: Encephalitis kills at least 430 in India

Related Stories

Encephalitis kills at least 430 in India

October 15, 2011

At least 430 people, mainly children, have died from an outbreak of encephalitis in a deeply neglected region of the northern Indian state of Uttar Pradesh, officials said on Saturday.

Indian firm unveils latest typhoid shots

August 29, 2013

An Indian pharmaceutical firm said Thursday it would soon launch the world's first vaccine against typhoid which can be given to infants, protecting the most vulnerable victims of the illness.

Time to get a flu shot, CDC says

September 30, 2013

More than half of the children in the United States were vaccinated against influenza during the 2012-13 flu season, along with more than 4 in 10 adults, according to the Centers for Disease Control and Prevention. Overall, ...

Brazil to test new vaccine against dengue fever

September 26, 2013

Brazilian scientists will next month begin clinical tests on humans of a new vaccine against dengue fever, a leading Sao Paulo-based biomedical research institute said Thursday.

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.